Insider Trading activities of Boston Scientific Corp insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,762,101.
The total value of stock sales since 2005 is $869,016,554.
The total value of stock option exercises since 2005 is $78,809,293.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,121 .00 0
2014-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,115 .00 0
2014-02-16 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 3,373 .00 0
2014-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,723 .00 0
2014-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,723 .00 0
2014-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,588 .00 0
2014-02-16 Onuscheck John Michael (SVP & President, Europe) Option Ex 5,060 .00 0
2014-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,434 .00 0
2014-02-16 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 6,747 .00 0
2014-02-14 Sununu John E (Director) Sale 29,561 13.17 389,318
2014-02-13 Johnson Kristina M (Director) Sale 18,000 13.01 234,108
2014-02-06 Mario Ernest (Director) Sale 17,104 12.80 218,931
2014-02-03 Mario Ernest (Director) Sale 10,000 13.19 131,880
2014-01-15 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.19 178,105
2014-01-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-01-06 Mario Ernest (Director) Sale 10,000 12.50 125,000
2014-01-03 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 14,925 .00 0
2013-12-26 Mario Ernest (Director) Sale 10,000 12.06 120,600
2013-11-27 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 108,595 11.70 1,270,561
2013-11-26 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 85,106 11.82 1,005,697
2013-11-26 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 46,701 6.59 307,993
2013-11-25 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Sale 33,334 12.05 401,674
2013-11-25 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 242,504 12.02 2,915,140
2013-11-25 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 242,504 7.39 1,792,104
2013-11-22 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 150,000 12.02 1,803,150
2013-11-22 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 150,000 7.82 1,173,000
2013-11-21 Dawkins Keith D (EVP, Global Chief Med. Off.) Sale 138,850 12.00 1,666,338
2013-11-21 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 138,850 7.62 1,058,453
2013-11-19 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Sale 20,132 11.94 240,376
2013-11-11 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 6,000 12.02 72,126
2013-11-08 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 20,000 11.87 237,399
2013-11-08 Mario Ernest (Director) Sale 135,645 11.73 1,591,387
2013-11-01 Mahoney Michael F (President & CEO) Option Ex 341,669 .00 0
2013-11-01 Fitzgerald Joseph Michael (SVP & President, CRM) Sale 9,236 11.69 107,978
2013-10-28 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 2,594 .00 0
2013-08-29 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 525,000 10.70 5,614,875
2013-08-29 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 475,000 7.41 3,519,750
2013-08-16 Fitzgerald Joseph Michael (SVP & President, CRM) Sale 9,202 11.02 101,424
2013-08-14 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Sale 38,171 11.28 430,645
2013-07-29 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 6,665 .00 0
2013-07-29 Onuscheck John Michael (SVP & President, EMEA) Option Ex 4,165 .00 0
2013-07-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,364 .00 0
2013-07-28 Pierce David A (SVP and President, Endoscopy) Option Ex 234 .00 0
2013-07-02 Prange Karen (SVP&Pres, Uro & Women's Health) Option Ex 25,862 .00 0
2013-06-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 14,665 .00 0
2013-05-31 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 10,941 9.37 102,495
2013-05-30 Carruthers Wendy (SVP, Human Resources) Sale 25,001 9.15 228,884
2013-05-29 Connors Nelda J (Director) Sale 24,116 9.17 221,143
2013-05-12 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 7,235 .00 0
2013-05-06 Mario Ernest (Director) Buy 30,000 7.76 232,800
2013-05-01 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,746 .00 0
2013-02-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 4,190 .00 0
2013-02-28 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 5,586 .00 0
2013-02-28 Carruthers Wendy (SVP, Human Resources) Option Ex 2,793 .00 0
2013-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 3,491 .00 0
2013-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,269 .00 0
2013-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 4,888 .00 0
2013-02-28 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 3,491 .00 0
2013-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 8,379 .00 0
2013-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,190 .00 0
2013-02-28 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,237 .00 0
2013-02-28 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 10,474 .00 0
2013-02-28 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 10,474 .00 0
2013-02-28 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 10,474 .00 0
2013-02-27 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 2,388 .00 0
2013-02-27 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,184 .00 0
2013-02-27 Carruthers Wendy (SVP, Human Resources) Option Ex 4,617 .00 0
2013-02-27 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 3,184 .00 0
2013-02-27 Mahoney Michael F (President & CEO) Option Ex 57,324 .00 0
2013-02-27 Pierce David A (SVP and President, Endoscopy) Option Ex 7,165 .00 0
2013-02-27 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 6,369 .00 0
2013-02-27 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 8,758 .00 0
2013-02-27 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 9,952 .00 0
2013-02-27 Phalen Michael P. (EVP & President, MedSurg) Option Ex 10,350 .00 0
2013-02-27 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 7,961 .00 0
2013-02-27 Onuscheck John Michael (SVP & President, EMEA) Option Ex 7,961 .00 0
2013-02-27 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 13,535 .00 0
2013-02-27 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 13,535 .00 0
2013-02-27 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 18,312 .00 0
2013-02-24 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,012 .00 0
2013-02-24 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,146 .00 0
2013-02-24 Carruthers Wendy (SVP, Human Resources) Option Ex 3,012 .00 0
2013-02-24 Pierce David A (SVP and President, Endoscopy) Option Ex 3,012 .00 0
2013-02-24 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,109 .00 0
2013-02-24 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 2,410 .00 0
2013-02-24 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,326 .00 0
2013-02-24 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,699 .00 0
2013-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2013-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2013-02-24 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 3,012 .00 0
2013-02-24 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 3,012 .00 0
2013-02-23 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 8,065 .00 0
2013-02-16 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 11,471 .00 0
2013-02-16 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 11,471 .00 0
2013-02-16 Carruthers Wendy (SVP, Human Resources) Option Ex 4,359 .00 0
2013-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,122 .00 0
2013-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,116 .00 0
2013-02-16 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 3,374 .00 0
2013-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,724 .00 0
2013-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,724 .00 0
2013-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,589 .00 0
2013-02-16 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,061 .00 0
2013-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,435 .00 0
2013-02-16 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 6,748 .00 0
2013-02-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 20,244 .00 0
2013-02-12 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 5,913 .00 0
2013-02-12 Carruthers Wendy (SVP, Human Resources) Option Ex 2,639 .00 0
2013-02-12 Pierce David A (SVP and President, Endoscopy) Option Ex 3,214 .00 0
2013-02-12 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 5,393 .00 0
2013-02-12 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 2,000 .00 0
2013-02-12 Phalen Michael P. (EVP & President, MedSurg) Option Ex 3,278 .00 0
2013-02-12 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,198 .00 0
2013-02-12 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,996 .00 0
2013-02-12 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 4,794 .00 0
2013-01-07 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 10,775 .00 0
2013-01-03 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 14,925 .00 0
2012-11-13 Nicholas Nj Jr (Director) Buy 20,000 5.28 105,600
2012-11-09 Nicholas Nj Jr (Director) Buy 25,000 5.17 129,299
2012-11-01 Mahoney Michael F (President & CEO) Option Ex 341,669 .00 0
2012-10-30 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 4,580 .00 0
2012-10-30 Onuscheck John Michael (SVP & President, EMEA) Option Ex 2,290 .00 0
2012-09-07 Spriggs Otha T. Iii (SVP, Human Resources) Option Ex 7,198 .00 0
2012-08-06 Mario Ernest (Director) Buy 32,000 5.29 169,280
2012-07-31 Mahoney Michael F (President) Buy 22,000 5.19 114,136
2012-07-31 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,118 .00 0
2012-07-31 Kucheman William (Chief Executive Officer) Buy 10,000 5.21 52,089
2012-07-29 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 6,667 .00 0
2012-07-29 Onuscheck John Michael (SVP & President, EMEA) Option Ex 4,167 .00 0
2012-07-28 Pierce David A (SVP and President, Endoscopy) Option Ex 234 .00 0
2012-06-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 14,662 .00 0
2012-05-12 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 7,236 .00 0
2012-05-10 Neumann Lawrence R (SVP, Special Projects) Option Ex 1,288 .00 0
2012-05-07 Onuscheck John Michael (SVP & President, EMEA) Option Ex 2,350 .00 0
2012-05-01 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,750 .00 0
2012-02-28 Neumann Lawrence R (SVP, Special Projects) Option Ex 5,238 .00 0
2012-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 3,492 .00 0
2012-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,270 .00 0
2012-02-28 Spriggs Otha T. Iii (SVP, Human Resources) Option Ex 4,540 .00 0
2012-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 4,889 .00 0
2012-02-28 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 3,492 .00 0
2012-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 8,380 .00 0
2012-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,190 .00 0
2012-02-28 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,238 .00 0
2012-02-28 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 10,475 .00 0
2012-02-28 Kucheman William (Chief Executive Officer) Option Ex 13,967 .00 0
2012-02-28 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 10,475 .00 0
2012-02-28 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 7,682 .00 0
2012-02-28 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 10,475 .00 0
2012-02-24 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 4,217 .00 0
2012-02-24 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,109 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.